Biomarcadores cardiacos como ayuda diagnóstica en las cardiopatías

Ricardo Correa; Santiago Galvis

doi:10.16925/sp.v10i20.885

Cardiac Biomarkers to Help Diagnose Cardiopathies

Revisión

https://doi.org/10.16925/sp.v10i20.885

Ricardo Correa Ver Biografía

Universidad de Caldas

Santiago Galvis Ver Biografía

Universidad de Caldas

In the daily clinic of small animals, it is very common to find cardiac pathologies, which are diagnosed using imageology examinations like radiology, electrocardiograms and echocardiography. However, in spite of the broad researches on such techniques, it is still hard to clearly make the patient’s prognosis and objectively evaluate such pathologies. There are even patients with hidden heart diseases that may not be observed in the clinical and imageology examinations. Therefore, new methods have been studied in the past years to quickly and effectively diagnose heart diseases. Such is the case of cardiac biomarkers, like troponins and natriuretic peptides, which are more frequently used in human and animal medicine to help make the diagnosis, prognosis and evolution of heart issues in a very precisely and specifically manner. This article is intended to update the concepts on cardiac biomarkers in heart diagnosis of cats and dogs.

Keywords: caninos, enfermedad cardiaca, péptido natriurético, troponina

Fonfara S, Loureiro J, Swift S, James R, Cripps P, Dukes-McEwan J. Cardiac Troponin I as a Marker for Severity and Prognosis of Cardiac Disease in Dogs. Vet J. 2010);184(3):334-9.

Oyama MA. Evaluation of Heart Function Using Blood-Based Test: Current Use and Future Applications. Documento presentado en el Congreso Internacional de la Asociación de Veterinarios de Animales de Compañía. 2006 may 19-21; Rimini.

Mosbasheri A, Cassidy JP. Biomarkers in Vet erinary Medicine: Towards Targeted, Individualized Therapies for Companion Animals. Vet J. 2010;185(1):1-3.

Oyama MA, Reynolds C. Biomarkers in the diagnosis of canine heart disease. Veterinary Focus. 2008;18(3):1-6.

Miyazaki M, Rosenblum J, Kasahara Y, Nakaga wa I, Patricelli MP. Determination of Enzymatic Source of Alanine Aminotransferase Activity in Serum from Dogs with Liver Injury. J Pharmacol and Toxicol Methods. 2009;60(3):307-15.

Landenson JH. A Personal History of Markers of Myocyte Injury (Myocardial Infarction). Clin Chim Acta. 2007;381(1):3-8.

Lopez-Sendo J. Troponinas y otros marcadores de daño miocardico. Mitos y realidades. Rev Esp Cardiol. 2003;56(1);9-16.

Shinde SB. Relevant Cardiac Biochemical Markers. Bombay Hospital Journal. 2004;46(4).

Solter PF. Clinical Biomarkers of Cardiac Injuries and Disease. ACVP/ASVCP. Annual Meetings. Savannah: IVIS; 2007. p. 10-4.

Fox PR, Oyama MR. Utility of Plasma n -Terminal Pro-Brain Natriuretic Peptide ( NT -PRO BNP ) to Distinguish between Congestive Heart Failure and Non-Cardiac Causes of Acute Dyspnea in Cats. J Vet Cardiol. 2009;11(Supl 1):S51-S61.

Kimmenade V, Januzzi J, Roland RJ. The Evolution of the Natriuretic Peptides - Current Applications in Human and Animal Medicine. J Vet Cardiol. 2009;11(Supl 1):S9-21.

Papageorgiou N, Tousoulis D. Is HDL a Prognostic Biomarker for Coronary Atherosclerosis? Intern J Cardiol. 2014;174(3):465-7.

Saunders AB, Smith BE, Fosgate G, Suchodolski JS, Steiner JM. Cardiac Troponin I and C-Reactive Protein Concentrations in Dogs with Severe Pulmonic Stenosis before and after Balloon Valvuloplasty. J Vet Cardiol. 2009;11(1):9-16.

Beardow A. Veterinary Cardiology Diagnostics. IdeXX Laboratories. 2008;1(2):12-5.

O’brien PJ, Smith DEC, Knechtel TJ, et al. Cardiac Troponin I is a Sensitive, Specific Biomarker of Cardiac Injury in Laboratory Animals. Lab Anim. 2006;40(2):153-71.

Jaffe AS, Ordoñez-llanos J. Troponinas ultrasensibles en el dolor torácico y los síndromes coronarios agudos, ¿un paso hacia adelante? Rev Esp Cardiol. 2010;63(7):763-9.

Capdevila C, Portoles M, Hernandiz A, Pallares V, Cosin J. La troponina T como posible marcador de daño miocárdico menor. Su aplicación en el miocardio aturdido y en la isquemia silente. Rev Esp Cardiol. 2001;54:508-91.

Caro-Vadillo A. Troponinas: marcadores de lesión miocárdica en perros. Clin Vet Peq Anim. 2005;25(3):183-187.

Sleeper M, Clifford CA, Laster LL. Cardiac Troponin I in the Normal Dog and Cat. J Vet Intern Med. 2001;15(5):501-3.

Ventura M, Blanco LM, Tuñon J, Muñoz B, Madrigal J, Moreno JA, et al. Biomarcadores en la medicina vascular. Rev Esp Cardiol. 2009;62(6);677-88.

Oyama MA, Sisson DD. Blood-Based Detection of Occult Heart Disease. En: Annual Veterinary Medical Forum, 21, 2001. Charlotte: American College of Veterinary Internal Medicine; 2003. p. 88-9.

Kocaturk M, Mart í nez S, Eralp O, Tvarijonaviciute A. Tei Index (Myocardial Performance Index) and Cardiac Biomarkers in Dogs with Parvoviral Enteritis. Res in Vet Sci. 2012;92(1):24-9.

Ljubica SK, Drajisa RT, Radomir R. Resting and Dobutamine Stress Test Induced Serum Concen trations of Brain Natriuretic Peptide in German Shepherd Dogs. Res Vet Sci. 2012;93(3):1446-53.

Trafny D, Oyama M, Wormser C, Reynolds C. Cardiac Troponini Concentrations in Dogs with Bradyarrhytmias before and after Artificial Pacing. J Vet Cardiol. 2010;12(3):183-90.

Verbiest T, Binst D, Waelbers T, Coppieters E, Polis I. Perioperative Changes in Cardiac Troponin I Concentrations in Dogs. Res Vet Sci. 2013;94(3):446-8.

Caragher TE, Fernández BB, Jacobs FL, Barr LV. Evaluation of Quantitative Cardiac Biomarker Point-of-Care Testing in the Emergency Department. J Emerg Med. 2002;22(1):1-7.

Healey JS, Davies RF, Smith SJ. Prognostic Use of Cardiac Troponin t and Troponin i in Patients with Heart Failure. Can J Cardiol. 2003;19(4):3836.

Peacock WF, De Marco T, Fonarow GC. Cardiac Troponin and Outcome in Acute Heart Failure. N Engl J Med. 2008;358(20):2117-26.

Al-Otaiby, Al-Amri, Al-Moghairi. The Clinical Significance of Cardiac Troponins in Medical Practice. J Saudi Heart Assoc. 2011;23(1):3-11.

Cakiroglu, D. Meral, Y. Bakirel, U. Kazanci, D. Cardiac Troponin Levels in Dogs with Dilate Cardiomyopathy. Kafkas Univ Vet Fak Derg. 2009;15(1):13-7.

Pruvot S, Galidie G, Bergmann JF, Mah é I. Troponin and Others Markers of Myocardial Ischemia Injury, Which Relevance in Internal Medicine? Rev Med Interne. 2006;27(3):215-26.

Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS. ACC/AHA Guidelines for the Management of Patients with Unstable Angina and nonst Segment Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Manage ment of Patients with Unestable Angina). J Am Coll Cardiol. 2000;36(3):970-1062.

Connolly DJ, Soares RJ. Circulating Natriuretic Peptides in Cats with Heart Disease. J Vet Intern Med. 2008;22(1):96-105.

Maack T. The Broad Homeostatic Role of Natriuretic Peptides. Arq Bras Endocrinol Metabol. 2006;50(2):198-207.

Richards AM. Nuevos biomarcadores en la insufi ciencia cardiaca; aplicaciones en el diagnóstico, pronóstico y pautas de tratamiento. Rev Esp Cardiol. 2010;63(6):635-9.

Felker, GM, Petersen JW, Mark DB. Natriuretic Peptides in the Diagnosis and Management of Heart Failure. CMAJ. 2006;175(6):611-7.

Bonet AL, Mart í nez-Dolz L. Péptidos natriuréticos en insuficiencia cardiaca. Rev Esp Cardiol. 2006;6(F):15-26.

Trachsel DS, Grenacher B, Weishaupt MA, Schwarzwald CC. Plasma atrial natriuretic peptide concentrations in horse with heart disease, a pilot study. Vet J. 2012;192(2):166-70.

Trachsel DS, Schwarzwald CC, Grenacher B, Weishaupt MA. Analytic Validation and Com parison of Three Commercial Immunoassays for Measurement of Plasma Atrial/a-Type Natriuretic Peptide Concentration in Horses. Res Vet Sci. 2014;96(1):180-6.

Ruskoaho H. Cardiac Hormones as Diagnostic Tools in Heart Failure. Endocr Rev. 2003;24(3):34156.

Mair J, Hammerer-Lercher A, Puschendorf B. The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure. Clin Chem Lab Med. 2001;39:571-88.

Futterman LG, Lamberg L. Novel Markers in the Acute Coronary Syndrome: BNP , IL -6, PAPP-A. Am J Crit Care. 2002;11(2):168-72.

Alves de Souza RC, Camacho AA. Neurohor monal, Hemodynamic and Alectrocardiographic Evaluations of Healthy Dogs Receiving LongTerm Administration of Doxorubicin. Am J Vet Res. 2006;67(10):1779.

MacDonald KA, Kettleson MD, Munro C, Kass P. Brain Natriuretic Peptide Concentration in Dogs with Heart Disease and Congestive Heart Failure. J Vet Intern Med. 2003;17(2):172-7.

Oyama MA, Rush JE, Fox PR. Assessment of Serum n-Terminal Prob-Type Natriuretic Peptide Concentration for Differentiation of Congestive Heart Failure from Primary Respiratory Tract Dis ease as the Cause of Respiratory Signs in Dogs. J Am Vet Assoc. 2009;235(11):1319-25.

Oyama MA, Sisson D, Solter PF. Prospective Screening for Occult Cardiomyopathy in Dogs by Measurement of Plasma Atrial Natriuretic Peptide, B-Type Natriuretic Peptide and Cardiac Troponin I Concentrations. Am J Vet Res. 2007;68(1):42-7.

Haggstrom J, Hansson K, Kvart C, Pedersen H. Relationship between Different Natriuretic Peptides and Severity of Naturally Acquired Mitral Regur gitation in Dogs with Chronic Myxomatous Valve Disease. J Vet Cardiol. 2000;2(1):7-16.

Kellihan H, Mackie B, Stepien R. NT-proBNP , NT-proANP and ctnI concentrations in dogs with precapillary pulmonary hypertension. J Vet Cardiol. 2011;13(3):171-82.

Prosek R, Sisson DD, Oyama MA, Solter PF. Dis tinguish plasma atrial natriuretic factor, B-type natriuretic factor, endothelin and cardiac troponin I in cardiac and noncardiac dyspnea in 48 dogs using. J Vet Intern Med. 2007;21(2):238-42.

Carretón E, Morchón R, Gonzáles-Miguel M, Juste M, Simón F, Montoya-Alonso JA. Utility of cardiac biomarkers during adulticide treatment of heartworm disease ( Dirofilaria immitis ) in dogs. Vet Parasitol. 2013;197(1-2):244-50.

Correa , R., & Galvis , S. (2014). Cardiac Biomarkers to Help Diagnose Cardiopathies. Spei Domus, 10(20), 41-48. https://doi.org/10.16925/sp.v10i20.885

Download Citation

En calidad de autor del artículo, declaro que este, es un trabajo original, inédito, de mi creación exclusiva, que no se ha postulado a evaluación simultánea en otra publicación y que no cuenta con algún impedimento de cualquier naturaleza para la concesión de los derechos previstos en este contrato.

En ese sentido, me comprometo a esperar un resultado de evaluación de la revista, antes de considerar su presentación a otro medio, en caso de que la respuesta de publicación no sea positiva; adicionalmente, me comprometo a responder por cualquier acción de reivindicación, plagio u otra clase de reclamación que al respecto pudiera sobrevivir por parte de terceros.

Asimismo, declaro que como autor o coautor, estoy de acuerdo por completo con los contenidos presentados en este trabajo y cedo todos los derechos patrimoniales, es decir, la reproducción, comunicación pública, distribución, divulgación, transformación, puesta a disposición y demás formas de explotación de la obra por cualquier medio o procedimiento, a la revista y a la Editorial de la Universidad Cooperativa de Colombia.

Issue

Vol. 10 No. 20 (2014)

Published

2014-06-01

Downloads

PDF (Spanish)

Metrics

Metrics Loading ...

https://plu.mx/plum/a/?doi=10.16925/sp.v10i20.885